The proposed changes to the Medicare Shared Savings Program may put a damper on the accountable care organization (ACO) movement, but ACOs remain the government’s best option for controlling healthcare costs, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.
The proposed changes to the Medicare Shared Savings Program may put a damper on the accountable care organization (ACO) movement, but ACOs remain the government’s best option for controlling healthcare costs, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.
Transcript
What do you think the impact of the proposed MSSP changes will be on new ACOs looking to join?
I’m afraid from talking with many ACOs here at the conference [NAACOS fall 2018 meeting] and just looking at some of the responses that I’ve seen written, I think it is going to put a damper on the number that will be applying. I was speaking with one large well-known health system last night that had wished to enter the MSSP starting January 1. They’re here at the conference, but they’re not sure how their administrative department is going to take the 25% upside. While they are excited and optimistic about becoming an ACO, they’re not sure that the administration of the health system will allow that with the increased risk and also the lower rewards.
Do you think the proposed changes could hamper the ACO movement? Do you see more private payers stepping in to set up contracts?
I still think that the government’s best option for controlling healthcare costs is the accountable care organization and the standard fee-for-service Medicare. And I think that while there may be fewer ACOs in the program, and maybe a smaller number entering, I still think there will be a core that will continue to be there and will continue to be successful. And my hope would be that we would grow the movement, but that may take a longer period of time before we’re able to accomplish that.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More